Molecule Structure

Scientific Name

Carteolol

Description of the Drug

Carteolol is a beta adrenergic antagonist used to treat arrhythmia, angina, hypertension, and glaucoma.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00521

Brand Name(s)

Not Available

Company Owner(s)

Abbvie Inc, Sandoz Inc, Novartis Pharmaceuticals Corp, Apotex Inc, Bausch And Lomb Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Adrenergic receptor beta PROTEIN FAMILY ANTAGONIST CHEMBL2094118

Unichem Links

SureChEMBL SCHEMBL23721779 SCHEMBL24810
PharmGKB PA164768736
Human Metabolome Database HMDB0014662
WDI CARTEOLOL
DrugBank DB00521
PubChem: Thomson Pharma 14849226
PubChem 2583
LINCS LSM-1541
Nikkaji J13.087G
EPA CompTox Dashboard DTXSID3022746
DrugCentral 520
ChemicalBook CB0268673
Guide to Pharmacology 7142
GSRS db81bf1f-0a83-495a-9138-9936772c8cf1
rxnorm CARTEOLOL HYDROCHLORIDE CARTEOLOL OCUPRESS
KEGG Ligand C06874
ChEBI 3437